Nausea drug is cleared for chemotherapy patientsDetroit News, MI - Jul 25, 2003 ... Merck & Co. earlier this year won US approval of its Emend drug for nausea and
vomiting, which is used in combination with medicines such as Zofran.
Merck Lowers Sales Estimate For a Top Drug
New York Times - Jul 21, 2003
... drugs, like the asthma treatment Singulair, will help make up for slowing sales of
Zocor this year, though new drugs including the antinausea therapy Emend and ...
Merck Lowers Zocor Estimate, Says 2nd-Qtr Profit Rose (Update6)
Bloomberg - Jul 21, 2003
... other drugs such as the asthma treatment Singulair will help make up for slowing
sales of Zocor this year, though new drugs including anti-nausea therapy Emend ...
Merck Lowers Zocor Estimate, Says 2nd-Qtr Profit Rose (Update5)
Bloomberg - Jul 21, 2003
... The company's new drugs include the anti-nausea therapy Emend and
Zetia, a cholesterol medicine developed with Schering-Plough. ...
Merck Lowers Zocor Estimate, Says 2nd-Qtr Profit Rose (Update4)
Bloomberg - Jul 21, 2003
... The company's new drugs include the anti-nausea therapy Emend and
Zetia, a cholesterol medicine developed with Schering-Plough. ...
Merck Announces Second - Quarter 2003 Earnings Per Share - EPS - ...
Business Wire (press release) - Jul 21, 2003
... One such product, EMEND, a new drug used with other anti-emetic agents for the prevention
of highly emetogenic chemotherapy-induced nausea and vomiting, became ...
